Sun Pharma Gets SAHPRA Approval for Generic Semaglutide Injection in South Africa for Type 2 Diabetes
The approval gives Sun Pharma a pre-filled semaglutide pen for adults with type 2 diabetes and expands its generic drug reach.
- On Wednesday, the South African Health Products Regulatory Authority approved Sun Pharmaceutical Industries Ltd to manufacture and market generic semaglutide for adults with inadequately controlled type 2 diabetes.
- Rapid urbanization and changing lifestyles have driven growing type 2 diabetes prevalence in South Africa, placing significant pressure on patients and healthcare services, the company said.
- Sun Pharma will sell the medication as a pre-filled, multi-dose injectable pen in two strengths—2 mg/1.5 mL and 4 mg/3 mL—allowing flexible, once-weekly dosing.
- Competition for Eli Lilly and Novo Nordisk is intensifying as generic semaglutide challenges market dominance of Mounjaro, Ozempic, and Wegovy following recent patent expirations.
- Sun Pharma Chief Operating Officer Aalok Shanghvi said the company remains "committed to improving access to generics," with product launch planned for the coming days.
12 Articles
12 Articles
India’s Sun Pharma gets South Africa nod for generic semaglutide after Novo Nordisk patent expiry
India’s Sun Pharma has received South Africa’s approval to launch a generic semaglutide injection after Novo Nordisk’s patent expiry, intensifying competition in the Ozempic and weight-loss drug market
Sun Pharma Wins SAHPRA Nod to Manufacture, Market Generic Semaglutide Injection in South Africa
New Delhi: Sun Pharmaceutical Industries Limited has received approval from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of semaglutide...
India’s Sun Pharma wins South Africa approval to launch generic Ozempic
By Nqobile Dludla JOHANNESBURG, July 15 (Reuters) - India's Sun Pharmaceutical Industries has received approval from South Africa's health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk's top...
Sun Pharma gets South Africa nod for generic semaglutide
Revital, Sun Pharma's flagship multivitamin brand, has launched a new integrated campaign featuring Bollywood actor Vicky Kaushal, betting on a broader conversation around energy, stress and modern lifestyles rather than traditional messaging centred on physical tiredness.
Coverage Details
Bias Distribution
- 56% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
